methoxyhydroxyphenylglycol has been researched along with Marfan Syndrome, Type I in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adcock, EW; Butler, IJ; Caprioli, RM; Denson, SE; Howell, RR; Morriss, FH; Seifert, WE; Stoerner, JW | 1 |
1 other study(ies) available for methoxyhydroxyphenylglycol and Marfan Syndrome, Type I
| Article | Year |
|---|---|
CSF neurotransmitter studies. An infant with ascorbic acid-responsive tyrosinemia.
Topics: Ascorbic Acid; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant, Newborn; Infant, Premature; Marfan Syndrome; Methoxyhydroxyphenylglycol; Phenylacetates; Tyrosine | 1980 |